Multisite Is Superior to Single-Site Intratumoral Chemotherapy to Retard the Outcomes of Pancreatic Ductal Adenocarcinoma in a Murine ModelJanette Lazarovits, Jacob Ben Arie, Ron Epelbaum et al.|Cancers|2023Cited by 4
MULTISITE INTRATUMORAL CHEMOTHERAPY RETARDS GROWTH OF PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IN A MURINE MODELJanette Lazarovits, Jacob Benarie, Ron Epelbaum et al.|Gastrointestinal Endoscopy|2023Cited by 0
P-77 Multisite intratumoral chemotherapy improves treatment outcome in a murine model with pancreatic ductal adenocarcinomaRon Epelbaum, Janette Lazarovits, Jesse Lachter et al.|Annals of Oncology|2023Cited by 0